China Expansion: R&D Staffs Growing Rapidly – Shanghai Forum
This article was originally published in PharmAsia News
Executive Summary
SHANGHAI - GlaxoSmithKline plans to double its R&D staff in China to roughly 350 by the end of 2009, GlaxoSmithKline China's R&D head of operation management and alliances Carol Zhu said during the ChinaBio Investor Forum 2008
You may also be interested in...
Biomagnetics Enters China Through Joint Venture With ACGT DNA Technologies
SHANGHAI - Biomagnetics Diagnostics has entered into a joint venture with DNA sequencing and synthesis firm ACGT DNA Technologies to set up a subsidiary in China to explore the country's biotech diagnostic market
Biomagnetics Enters China Through Joint Venture With ACGT DNA Technologies
SHANGHAI - Biomagnetics Diagnostics has entered into a joint venture with DNA sequencing and synthesis firm ACGT DNA Technologies to set up a subsidiary in China to explore the country's biotech diagnostic market
3D Biotek CEO Qing Liu On Opening A Production Facility In China: An Interview With PharmAsia News
Founded in April 2007, New Jersey-based 3D Biotek is a pharmaceutical company focused on three-dimensional microfabrication technology and biomanufacturing technology for stem cell cultures, tissue engineering and drug discovery applications.CEO and Founder Qing Liu talked to PharmAsia News' Shanghai bureau about the company's first commercialized product, 3D Insert, and about moving the company's production facilities to China.